Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale Major Shareholding Notification 2021

Oct 26, 2021

1671_mrq_2021-10-26_515d85f8-6885-400b-9b3d-c816e318e1f8.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3147Q

Societe Generale SA

26 October 2021

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree
DraftKings Inc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure
25/10/2021
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"
YES: Entain plc

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 85,979 0.01 69,632 0.01
(2) Cash-settled derivatives: 29,633 0.00 700 0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 320,200 0.04 0 0.00
TOTAL: 435,812 0.05 70,332 0.01
Class of relevant security: 0% Convertible Senior Notes due 2028
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 4,200 0.33 0 0.00
(2) Cash-settled derivatives: 0 0.00 4,200 0.33
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0.00 0 0.00
TOTAL: 4,200 0.33 4,200 0.33

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit USD
Ordinary Purchase 10 46.872
Ordinary Purchase 100 46.745
Ordinary Purchase 700 46.75
Ordinary Purchase 100 46.75
Ordinary Purchase 200 46.79
Ordinary Purchase 500 46.79
Ordinary Purchase 100 46.75
Ordinary Purchase 20 46.76
Ordinary Purchase 80 46.76
Ordinary Purchase 300 46.79
Ordinary Purchase 105 46.785
Ordinary Purchase 100 46.75
Ordinary Purchase 100 46.75
Ordinary Sale 50 46.758
Ordinary Sale 50 46.758
Ordinary Sale 100 46.788
Ordinary Sale 100 46.588
Ordinary Sale 5 46.698
Ordinary Sale 95 46.678
Ordinary Sale 100 46.748
Ordinary Sale 1 46.788
Ordinary Sale 1 46.788
Ordinary Sale 100 46.668
Ordinary Sale 100 46.698
Ordinary Sale 33 46.628
Ordinary Sale 100 46.608
Ordinary Sale 100 46.588
Ordinary Sale 100 46.568
Ordinary Sale 100 46.668
Ordinary Sale 100 46.778
Ordinary Sale 100 46.538
Ordinary Sale 814 39.6953
Ordinary Sale 1,890 42.3997
Class of relevant security Purchase/sale Number of securities Price per unit EUR
Ordinary Sale 415 40.276
Ordinary Sale 637 39.158
Ordinary Sale 853 39.284
Ordinary Sale 500 39.95
Total Purchases 2,415
Total Sales 6,444

(b)        Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD
Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities Price per unit USD

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.
Expiry date Option money paid/ received per unit

USD

(ii)        Exercise

Class of relevant security Product description

e.g. call option
Exercising/ exercised against Number of securities Exercise price per unit USD

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion
Details Price per unit (if applicable) USD

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? Yes
###### Date of disclosure: 26/10/2021
###### Contact name: Paul Jenkins
###### Telephone number*: +44 20 7676 6969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1.         KEY INFORMATION

Full name of person making disclosure: SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: DraftKings Inc

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

-

Class of relevant security Product description e.g. call option Written or purchased Number of securities to which option or derivative relates Exercise price per unit USD Type Expiry date
e.g. American, European etc.
Ordinary Listed put option Sale 17,700 40 American   options 14/04/2022
Ordinary Listed put option Sale 20,500 40 American   options 15/07/2022
Ordinary Listed put option Sale 10,700 40 American   options 18/02/2022
Ordinary Listed put option Sale 28,700 45 American   options 19/11/2021
Ordinary Listed put option Sale 12,300 50 American   options 14/04/2022
Ordinary Listed put option Sale 29,800 50 American   options 19/11/2021
Ordinary Listed put option Sale 75,900 50 American   options 21/01/2022
Ordinary Listed put option Sale 17,200 50 American   options 20/01/2023
Ordinary Listed put option Sale 50,000 55 American   options 20/01/2023
Ordinary Listed put option Sale 42,400 40 American   options 20/01/2023
Ordinary Listed put option Sale 15,000 30 American   options 19/01/2024

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETFLFIFITLRFIL